21 May 2009
Leucocyte elastase-a1-protease inhibitor complex: marker of early and long-term kidney graft function
M Zynek-Litwin, J Kuzniar, Z Marchewka, W Kopec, M Kusztal, D Patrzalek, P Biecek, A Dlugosz, M KlingerAnn Transplant 2009; 14(1): 34-34 :: ID: 880320
Abstract
Background: Neutrophils are mediators of ischemia/reperfusion (I/R) injury following kidney transplantation (KTx). Leukocyte elastase complex with α[sub]1[/sub]-protease inhibitor (LE-α[sub]1[/sub]-PI) is a neutrophils degranulation marker. The study's aim was to evaluate LE-α[sub]1[/sub]-PI as marker of I/R kidney damage and to look for a correlation between leukocyte activation and posttransplant complications.
Material/Methods: The study was performed on 24 kidney graft recipients from the deceased donors. Plasma and urine LE-α[sub]1[/sub]-PI were analyzed 4 times in the first week after KTx (in postoperative (PO) days 1, 3, 7) and in a distant period after KTx. This was done by ELISA test.
Results: Peak of plasma LE-α1-PI complex level was on 1[sup]st[/sup] day after KTx and it was significantly higher than on 3[sup]rd[/sup] and 7[sup]th[/sup] PO days, as well as in a distant measurement (p<0.001; p<0.0001; p<0.001 respectively). The highest urine LE-α1-PI was observed on 3[sup]rd[/sup] PO day. Plasma and urine LE-α[sub]1[/sub]-PI on 1[sup]st [/sup]PO day was higher in DGF patients than in patients with IGF (p<0.02; p<0.0007 respectively). Significantly higher urine LE-α[sub]1[/sub]-PI excretion on 1[sup]st[/sup] PO day was observed in patients with longer cold ischemia time (CIT) - p<0.007. In patients with an early graft rejection urine LE-α[sub]1[/sub]-PI on 1[sup]st[/sup] and 7[sup]th[/sup] PO day was greater than in no-rejection group (p<0.009; p<0.04 respectively).
Conclusions: Our study is a presentation of non-invasive measurement of
neutrophils activation after KTx. It demonstrates a strong correlation between
test results: LE-α[sub]1 [/sub]-PI complex level and kidney graft function.
Keywords: Ischemia reperfusion injury, Kidney Transplantation
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






